Mineralys Therapeutics, Inc.
MLYS • NASDAQ
Mineralys Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jon Congleton, with a market cap of $2.0B.
CEOJon Congleton
Next Earnings
Upcoming earnings announcement for Mineralys Therapeutics, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.47
Earnings History
Past 12 earnings reports for Mineralys Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$0.40Est: -$0.54 | +25.9% | - | — |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.52Est: -$0.63 | +17.5% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.66Est: -$0.76 | +13.2% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.79Est: -$0.98 | +19.4% | - | — | 10-Q |
| Feb 12, 2025 | Q4 2024 | -$0.98Est: -$1.08 | +9.3% | - | — | 10-K |
| Nov 11, 2024 | Q3 2024 | -$1.13Est: -$0.83 | -36.1% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.83Est: -$0.70 | -18.6% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.70Est: -$0.67 | -4.5% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.61Est: -$0.82 | +25.6% | - | — | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.57Est: -$0.76 | +25.0% | - | — | — |
| Aug 7, 2023 | Q2 2023 | -$0.31Est: -$0.83 | +62.7% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.51Est: -$0.89 | +42.7% | - | — | — |